KALEIDO BIOSCIENCES, INC. Operating Cash Flow
KALEIDO BIOSCIENCES, INC. reported Operating Cash Flow of -$77.09 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-04-01
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$17.16M.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$15.88M.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2021-06-30 was -$20.08M.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2021-03-31 was -$23.97M.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$77.09M.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$61.52M.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$75.80M.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2018 was -$46.32M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$17.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | -$33.04M derived: sum of 2 quarters · filed 2022-04-01 | -$53.12M derived: sum of 3 quarters · filed 2022-04-01 | -$77.09M 10-K · filed 2022-04-01 |
| 2021-09-30 | -$15.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | -$35.96M derived: sum of 2 quarters · filed 2021-11-01 | -$59.93M 10-Q · filed 2021-11-01 | -$71.23M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-06-30 | -$20.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$44.06M 10-Q · filed 2021-08-11 | -$55.35M derived: sum of 3 quarters · filed 2022-04-01 | -$71.82M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-03-31 | -$23.97M 10-Q · filed 2021-05-04 | -$35.27M derived: sum of 2 quarters · filed 2022-04-01 | -$51.74M derived: sum of 3 quarters · filed 2022-04-01 | -$67.59M derived: sum of 4 quarters · filed 2022-04-01 |
| 2020-12-31 | -$11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | -$27.76M derived: sum of 2 quarters · filed 2022-04-01 | -$43.62M derived: sum of 3 quarters · filed 2022-04-01 | -$61.52M 10-K · filed 2022-04-01 |
| 2020-09-30 | -$16.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | -$32.32M derived: sum of 2 quarters · filed 2021-11-01 | -$50.22M 10-Q · filed 2021-11-01 | -$65.87M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | -$15.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$33.76M 10-Q · filed 2021-08-11 | -$49.40M derived: sum of 3 quarters · filed 2021-08-11 | -$67.09M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$17.90M 10-Q · filed 2021-05-04 | -$33.55M derived: sum of 2 quarters · filed 2021-05-04 | -$51.23M derived: sum of 3 quarters · filed 2021-05-04 | -$70.90M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | -$15.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$33.34M derived: sum of 2 quarters · filed 2021-03-03 | -$53.00M derived: sum of 3 quarters · filed 2021-03-03 | -$75.80M 10-K · filed 2021-03-03 |
| 2019-09-30 | -$17.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$37.35M derived: sum of 2 quarters · filed 2020-11-02 | -$60.15M 10-Q · filed 2020-11-02 | -$74.30M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | -$19.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$42.46M 10-Q · filed 2020-08-04 | -$56.61M derived: sum of 3 quarters · filed 2020-08-04 | -$69.15M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | -$22.80M 10-Q · filed 2020-05-14 | -$36.95M derived: sum of 2 quarters · filed 2020-05-14 | -$49.48M derived: sum of 3 quarters · filed 2020-05-14 | -$59.65M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$14.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$26.69M derived: sum of 2 quarters · filed 2020-03-02 | -$36.86M derived: sum of 3 quarters · filed 2020-03-02 | -$46.32M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$12.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$22.70M derived: sum of 2 quarters · filed 2019-10-30 | -$32.16M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | -$10.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$19.63M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | -$9.46M 10-Q · filed 2019-05-02 |